Experimental drug aims to help control weight in 44-Week trial
NCT ID NCT06703021
Summary
This study is testing whether a new medication called aleniglipron (GSBR-1290) can help people with obesity or overweight manage their weight when combined with diet and exercise. Researchers will compare the drug to a placebo in 82 participants over 44 weeks to see if it's safe and effective. The study focuses on adults who have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ACCESS II Research Site
Glendale, California, 91206, United States
-
ACCESS II Research Site
Montclair, California, 91763, United States
-
ACCESS II Research Site
Valparaiso, Indiana, 46383, United States
-
ACCESS II Research Site
West Des Moines, Iowa, 50265, United States
-
ACCESS II Research Site
Medford, Oregon, 97504, United States
-
ACCESS II Research Site
East Greenwich, Rhode Island, 02818, United States
-
ACCESS II Research Site
North Charleston, South Carolina, 29405, United States
-
ACCESS II Research Site
Dallas, Texas, 75042, United States
-
ACCESS II Research Site
San Antonio, Texas, 78240, United States
-
ACCESS II Research Site
West Jordan, Utah, 84088, United States
Conditions
Explore the condition pages connected to this study.